Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5.9% Following Analyst Downgrade
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s stock price dropped 5.9% during trading on Tuesday after Barclays lowered their price target on the stock from $22.00 to $5.00. Barclays currently has an overweight rating on the stock. Iovance Biotherapeutics traded as low as $3.20 and last traded at $3.21. Approximately 3,959,691 shares traded hands […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s stock price dropped 5.9% during trading on Tuesday after Barclays lowered their price target on the stock from $22.00 to $5.00. Barclays currently has an overweight rating on the stock. Iovance Biotherapeutics traded as low as $3.20 and last traded at $3.21. Approximately 3,959,691 shares traded hands […]